Chronic urticaria: not only after COVID-19 vaccination.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Yacoub MR;Yacoub MR;Yacoub MR; Ferlito A; Ferlito A; Nettis E; Nettis E
  • Source:
    Current opinion in allergy and clinical immunology [Curr Opin Allergy Clin Immunol] 2024 Oct 01; Vol. 24 (5), pp. 404-408. Date of Electronic Publication: 2024 Jul 30.
  • Publication Type:
    Journal Article; Review
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100936359 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-6322 (Electronic) Linking ISSN: 14736322 NLM ISO Abbreviation: Curr Opin Allergy Clin Immunol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Hagerstown, Md. : Lippincott Williams & Wilkins, c2001-
    • Subject Terms:
      Chronic Urticaria*/chemically induced ; COVID-19*/prevention & control ; COVID-19 Vaccines*/adverse effects ; Vaccination*/adverse effects; Adult ; Aged ; Child ; Humans
    • Abstract:
      Purpose of Review: To resume the current literature about vaccination and the onset of chronic urticaria.
      Recent Findings: The recent large-scale vaccination against SARS-CoV-2 targeting elderly, adult and children, has highlighted how vaccines can trigger onset or exacerbation of chronic urticaria.
      Summary: COVID-19 vaccines may act as triggers in the development of chronic spontaneous urticaria. More data regarding the other vaccines are necessary to evaluate a similar potential role. Proper education of patients with vaccine-induced chronic urticaria is essential to avoid vaccination hesitancy.
      (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
    • References:
      Grumach AS, Staubach-Renz P, Villa RC, et al. Triggers of exacerbation in chronic urticaria and recurrent angioedema-prevalence and relevance. J Allergy Clin Immunol Pract 2021; 9:2160–2168.
      Zuberbier T, Balke M, Worm M, et al. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol 2010; 35:869–873.
      Dobrican CT, Muntean IA, Pintea I, et al. Immunological signature of chronic spontaneous urticaria (Review). Exp Ther Med 2022; 23:381.
      Asero R, Tedeschi A. Chronic spontaneous urticaria: from the hunt for causes and pathogenesis to the identification of different endotypes. Eur Ann Allergy Clin Immunol 2023; 55:253–260.
      Asero R, Tedeschi A, Marzano AV, Cugno M. Chronic urticaria: a focus on pathogenesis. F1000Res 2017; 6:1095.
      Magen E, Shalom G, Waitman DA, Kahan N. Chronic spontaneous urticaria following vaccination. Int J Adv Res 2018; 6:1434–1439.
      Thomas J, Thomas G, Chatim A, et al. Chronic spontaneous urticaria after COVID-19 vaccine. Cureus 2021; 13:e18102.
      Brooks SG, De Jong AM, Abbaslou M, Sussman G. Chronic spontaneous urticaria triggered by the AstraZeneca/Oxford COVID-19 vaccine with achieved remission: a case report. Allergy Rhinol (Providence) 2022; 13:1–2.
      Suan D, Lee AYS. Chronic spontaneous urticaria following ChAdOx1-S COVID-19 vaccination. Allergo J Int 2022; 31:121–122.
      Ben-Fredj N, Chahed F, Ben-Fadhel N, et al. Case series of chronic spontaneous urticaria following COVID-19 vaccines: an unusual skin manifestation. Eur J Clin Pharmacol 2022; 78:1959–1964.
      Strahan A, Ali R, Freeman EE. Chronic spontaneous urticaria after COVID-19 primary vaccine series and boosters. JAAD Case Rep 2022; 25:63–66.
      Magen E, Yakov A, Green I, et al. Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2. Allergy Asthma Proc 2022; 43:30–36.
      de Montjoye L, Herman A, Baeck M. Chronic spontaneous urticaria following COVID-19 vaccination. JAAD Case Rep 2022; 25:35–38.
      Grieco T, Ambrosio L, Trovato F, et al. Effects of vaccination against COVID-19 in chronic spontaneous and inducible urticaria (CSU/CIU) patients: a monocentric study. J Clin Med 2022; 11:1822.
      Kocatürk E, Salameh P, Sarac E, et al. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: results of the UCARE COVAC-CU study. J Allergy Clin Immunol 2023; 152:1095–1106.
      Dev A, Sharma A, Bishnoi A, et al. Covid-19 vaccination and chronic urticaria: a paradigm study. Indian Dermatol Online J 2023; 14:637–642.
      Duperrex O, Tommasini F, Muller YD. Incidence of chronic spontaneous urticaria following receipt of the COVID-19 vaccine booster in Switzerland. JAMA Netw Open 2023; 6:e2254298.
      Kartal D, Orujova S, Ertaş R. Clinical effects of COVID-19 vaccines on chronic spontaneous urticaria patients: a study on two Turkish centers. Front Med (Lausanne) 2023; 10:1222126.
      Wolfson AR, Freeman EE, Blumenthal KG. Urticaria 12 days after COVID-19 mRNA booster vaccination. JAMA 2022; 327:1702–1703.
      Bianchi L, Hansel K, Biondi F, et al. Delayed urticaria after the third dose of mRNA COVID19 vaccine: a case series. Dermatol Ther 2022; 35:e15680.
      Drivenes JL, Banerji A, Bygum A. Delayed onset urticaria and symptomatic dermographism following COVID-19 booster vaccination: a case series. Clin Transl allergy 2022; 12:e12206.
      Dash S, Behera B, Sethy M, et al. COVID-19 vaccine-induced urticarial vasculitis. Dermatol Ther 2021; 34:e15093.
      Larson V, Seidenberg R, Caplan A, et al. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination. J Cutan Pathol 2022; 49:34–41.
      Tihy M, Menzinger S, André R, et al. Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines. J Eur Acad Dermatol Venereol 2021; 35:2456–2461.
      Holmes GA, Desai M, Limone B, et al. A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology. JAAD Case Rep 2021; 16:53–57.
      Daldoul M, Korbi M, Bellalah A, et al. Urticarial vasculitis triggered by SARS-CoV-2 vaccine (mRNA vaccine). J Eur Acad Dermatol Venereol 2022; 36:e743–e744.
      Hadj Hassine I. Covid-19 vaccines and variants of concern: a review. Rev Med Virol 2022; 32:e2313.
      Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect 2020; 80:607–613.
      Himed S, Gray A, Awethe Z, et al. SARS-CoV-2 infection and vaccination cutaneous manifestations for the inpatient dermatologist. Curr Dermatol Rep 2022; 11:252–262.
      Pignatti P, Ramirez GA, Russo M, et al. Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: basophil reactivity to excipients. Vaccine 2023; 41:4693–4699.
      Lam F, Shih CC, Chen TL, et al. Risk of urticaria in geriatric stroke patients who received influenza vaccination: a retrospective cohort study. Clin Interv Aging 2019; 14:2085–2093.
      Filippi F, Sechi A, Baraldi C, et al. Localized cold urticaria after vaccination in a child: a case and literature review. Allergol Int 2020; 69:645–647.
      Raison-Peyron N, Philibert C, Bernard N, et al. Cold contact urticaria following vaccination: four cases. Acta Derm Venereol 2016; 96:852–853.
      Tavadia S, Drummond A, Evans CD, Wainwright NJ. Leucocytoclastic vasculitis and influenza vaccination. Clin Exp Dermatol 2003; 28:154–156.
    • Accession Number:
      0 (COVID-19 Vaccines)
    • Publication Date:
      Date Created: 20240730 Date Completed: 20240829 Latest Revision: 20240830
    • Publication Date:
      20240830
    • Accession Number:
      10.1097/ACI.0000000000001019
    • Accession Number:
      39079165